| 121/222 | US=98 / Biol/Mol DiMaio D, Johung K, Goodwin EC, Horner SM, Yates KE. Senescence induced by repression of human papillomavirus oncogenes in cervical cancer cells. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 209-222. ISBN 978-084939192-7. SENESCENCIA INDUZIDA; REPRESSAO DOS ONCOGENES; CELULAS DE CANCER DO COLO DO UTERO. PAPILOMAVIRUS HUMANO |
| 122/222 | US=98 / Biol/Mol Roninson IB, Broude EV. Treatment-induced tumor cell senescence and its consequences. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 223-49. ISBN 978-084939192-7. CELULAS TUMORAIS. TRATAMENTO SENESCENCIA; ANTICARCINOGENICO; SENESCENCIA CELULAR TUMORAL |
| 123/222 | US=98 / Biol/Mol Rebbaa A. Senescence regulation in cancer therapy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 251-71. ISBN 978-084939192-7. |
| 124/222 | US=98 / Biol/Mol Kilic M, Schmitt CA. Exploiting drug-induced senescence in transgenic mouse models. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 273-94. ISBN 978-084939192-7. |
| 125/222 | US=98 / Biol/Mol Wu DY, Wang H, Wang Q, Wu PC, Vesselle HJ. Therapy-induced cellular senescence: clinical relevance, implications, and applications. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 295-306. ISBN 978-084939192-7. INDUZIDA PELA TERAPIA SENESCENCIA CELULAR; RELEVANCIA CLINICA; IMPLICACOES E APLICACOES; SENESCENCIA CELULAR ACELERADO; ACS |
| 126/222 | US=98 / Biol/Mol Dewey WC. How do cells die after irradiation? time-lapse studies of cells in culture. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 321-32. ISBN 978-084939192-7. CELULAS MORREM APOS IRRADIACAO; LAPSO TEMPORAL; ESTUDOS DE CULTURA CELULAR |
| 127/222 | US=98 / Biol/Mol Brown JM. Modes of cell death by anticancer agents: the crucial importance of dose. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 333-41. ISBN 978-084939192-7. |
| 128/222 | US=98 / Biol/Mol Broude EV, Loncarek J, Wada I, Cole K, Hanko C, Roninson IB. Mitotic catastrophe in cancer therapy. In: Roninson IB, Brown JM, Bredesen DE. Beyond apoptosis: cellular outcomes of cancer therapy. New York: Informa Helthcare, 2008. p. 307-20. ISBN 978-084939192-7. CATASTROFE MITOTICA. TERAPIA DO CANCER; CALCANHAR DE AQUILES. TUMORES; AGENTES ANTICANCERIGENOS |
| 129/222 | US=111 / Câncer Willimson KE, El Din OS, O'Kane HF. Apoptosis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 47-59. ISBN 978-0-470-01852-1. APOPTOSE; EQUILIBRIO SOBREVIVENCIA; CONTROLE GENETICO DA APOPTOSE; VIAS APOPTOTICAS; VIA DO RECEPTOR DE MORTE; RECEPTORES DE MORTE; FAMILIA BCL-2; PERMEABILIDADE MITOCONDRIAL; CASPASE; INIBIDOR DE PROTEINAS DE APOPTOSE; PROTEINAS ANTI-APOPTOTICAS; AVALIACAO DA APOPTOSE |
| 130/222 | US=35 / Câncer Mesa RA, Kaufmann SH. Molecular foundations of AML pathogenesis and physiology: altered apoptosis in AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 133-61. ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; APOPTOSE; RESISTENCIA MEDICAMENTOSA; BCL-2; MCL-1; XIAP; MICROAMBIENTE DA MEDULA OSSEA; RAS; FLT3 |
| 131/222 | US=49 / Câncer Jernberg-Wiklund H, Nilsson K. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I). In: Woude GFV, Klein G. Advances in cancer research. Amsterdam: Elsevier, 2007. p. 139-65. ISBN 978-0-12-006697-1. MIELOMA MULTIPLO HUMANO; INSULIN-LIKE GROWTH FACTOR I; IGF-I |
| 132/222 | US=57-B / Biol/Mol Weinberg RA. p53 and apoptosis: master guardian and executioner. In: ___. The biology of cancer. New York: Garland Science, 2007. p. 307-56. ISBN 0-8153-4078-8. P53; APOPTOSE; PAPOVAVIRUS; MUTANTES DE P53; NATUREZA DAS MUTACOES DO GENE P53; DANO AO DNA; GENOTIPO P53; RESPOSTAS CELULARES A RADIACAO; ACUMULACAO DE P53; CELULAS P53 MUTANTES |
| 133/222 | US=58 / Biol/Mol Blankenberg FG, Strauss HW. Imaging of apoptosis. In: Shields AF, Price P. In vivo imaging of cancer therapy. New Jersey: Humana Press, 2007. p. 303-16. (Cancer Drug Discovery and Development) ISBN 978-1-58829-633-7. IMAGEM DE APOPTOSE; LIPIDO PROTAO DE RESSONANCIA MAGNETICA; ESPECTROSCOPIA; AGENTES DE CONTRASTE PARA RESSONANCIA; CINTILOGRAFIA DE APOPTOSE |
| 134/222 | US=82 / Biol/Mol Schulz WA. Apoptosis and replicative senescence in cancer. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 145-65. ISBN 978-1-4020-6559-0. CANCER; APOPTOSE; SENESCENCIA REPLICATIVA; PROLIFERACAO CELULAR |
| 135/222 | US=92 / Biol/Mol Kaufmann SH. Apoptosis and alternative modes of cell death: the intrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 3-30. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CASPASES; CARCINOGENESE; BCL-2; AIP; RESISTENCIA AS DROGAS; DROGAS ANTICANCER |
| 136/222 | US=92 / Biol/Mol Ricci MS, El-Deiry WS. Apoptosis and alternative modes of cell death: the extrinsic pathway of apoptosis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 31-54. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; TNF; FAS; TRAIL; NF-KB; QUIMIOTERAPIA; RECEPTOR MORTE; RECEPTOR CHAMARIZ; VIA EXTRINSECA; AUTOIMUNIDADE |
| 137/222 | US=92 / Biol/Mol Wouters BG, Chiu RK. Apoptosis and alternative modes of cell death: evaluating the importance of apoptosis and other determinants of cell death and survival. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 55-72. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. APOPTOSE; CLONOGENICA SOBREVIVENCIA; SENESCENCIA; TERAPIA DO CANCER |
| 138/222 | US=92 / Biol/Mol Ianzini F, Mackey MA. Apoptosis and alternative modes of cell death: mitotic catastrople. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 73-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CATASTROFE MITOTICA; REGULACAO DO CICLO CELULAR; CICLINA B1; CELULAS ENDOPOLYPLOID; MITOSE; MEISIS; CARCINOGENESE; PROGRESSAO TUMORAL; RETARDADA DANOS NO DNA; SPCC |
| 139/222 | US=92 / Biol/Mol Djavaheri-Mergny M, Botti J, Codogno P. Apoptosis and alternative modes of cell death: autophagy and autophagic cell death. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 93-107. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. AUTOFAGIA; APOPTOSE; MORTE CELULAR; CANCER; MACROAUTOPHAGY; LISOSSOMO; TRANSDUCAO DE SINAL |
| 140/222 | US=92 / Biol/Mol McConkey DJ, Bondar V. Apoptosis and alternative modes of cell death: regulation and function of detachment-induced death (anoikis) in cancer progression and metastasis. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 109-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. |